Home-based Self-sampling for Cervical Cancer Prevention Education Intervention in Ghana

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-65
SponsorBaylor University

About this trial

The investigators propose to develop and/or adapt implementation strategies and a structured implementation plan to translate the HOPE intervention into existing healthcare practice in Ghana.

These "implementation support strategies (ISS)" are implementation strategies relevant to implementation support, which is concerned with moving (implementation) research into (implementation) practice.

The ultimate goal is to facilitate health system adoption and sustainment.

Eligibility criteria

Qualifiers

ability to give consent per Institutional Review Board stipulations

residing in the Central Region

having no medical characteristics that would interfere with the ability to participate fully

the willingness to participate in this study.

Disqualifiers

Women will be excluded if they are pregnant or have had a hysterectomy.

WLWH who have a cervix are the main target population to develop the HOPE toolkit.

Women who are below 25 and those who are above 65 years will be excluded.

Trial design

Treatments tested in this trial

  • Health providers and management at IG sites will receive ISS (i.e., management support, capacity-building, and social network support) and training on the HOPE implementation plan
  • Control Group

Treatment groups

1,500 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Baylor University

Lead sponsor

National Cancer Institute (NCI)

Collaborator